Routine anticoagulation for venous thromboembolism prevention following laparoscopic gastric bypass

Area of Science:

• Bariatric Surgery
• Vascular Surgery
• Surgical Outcomes

Background:

• Venous thromboembolism (VTE) is a significant risk following bariatric surgery.
• Traditional VTE prophylaxis often involves pharmacologic anticoagulation.

Purpose of the Study:

• To compare VTE rates using routine postoperative enoxaparin versus a strategy of early ambulation, sequential compression devices (SCDs), hydration, and selective anticoagulation.
• To evaluate the safety and efficacy of different VTE prophylaxis protocols in laparoscopic gastric bypass patients.

Main Methods:

• A retrospective study of 1,692 patients undergoing laparoscopic gastric bypass.
• Group A (n=435) received routine enoxaparin 12 hours post-surgery.
• Group B (n=1,257) received selective pharmacologic anticoagulation for high-risk patients only.

Main Results:

• Group B had shorter operating times and hospital stays.
• Incidence of intraluminal bleeding was lower in Group B (0.9%) vs. Group A (4.8%).
• Pulmonary embolism occurred in 1.1% of Group A and 0% of Group B; DVT rates were 1.7% (Group A) vs. 0.47% (Group B).

Conclusions:

• VTE prophylaxis can be achieved with SCDs, early ambulation, hydration, and shorter operating times.
• Bariatric surgery is safe without routine pharmacologic anticoagulation for non-high-risk patients.
• Minimizing anticoagulants reduces bleeding complications in bariatric surgery.